Bioequivalence and Bioavailability Forum 09:42 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

How to evaluate Stock solution stability according to EMA guideline [Bioanalytics]

posted by EKY - Thailand, 2018-05-23 03:59  - Posting: # 18800
Views: 1,408

(edited by Ohlbe on 2018-05-23 11:03)

From the "Guideline on bioanalytical method validation" (EMEA/CHMP/EWP/192217/2009 Rev. 1 Corr. 2**, 21 July 2011) in Topic "4.1.9 Stability" mentioned about the stability of stock and working solutions that ' It is not need to study the stability at each concentration level of working solutions and a bracketing approach can be used'.

Which concentration should be use for bracket study in this experiment? It is need to be at ULOQ and LLOQ concentration, or not?

Can use high and low QC concentration (HQC, LQC) for this experiment as same as the other stability evaluations (in matrix)?


Edit: category changed [Ohlbe]

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,761 posts in 3,996 threads, 1,265 registered users;
online 22 (1 registered, 21 guests [including 15 identified bots]).

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed